Finding of Mean Corpuscular Hemoglobin
|
phenotype |
|
Finding
|
653
|
1206
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Mean Corpuscular Volume (result)
|
phenotype |
|
Laboratory or Test Result
|
269
|
549
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Alkaline phosphatase measurement
|
phenotype |
|
Laboratory Procedure
|
42
|
79
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Red Blood Cell Count measurement
|
phenotype |
|
Laboratory Procedure
|
717
|
1599
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Malnutrition
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
417
|
29
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Malignant mesothelioma
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
420
|
12
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Craniodiaphyseal dysplasia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases
|
Disease or Syndrome
|
7
|
2
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Cervicogenic Headache
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Gastrointestinal mucositis
|
disease |
Digestive System Diseases; Stomatognathic Diseases
|
Disease or Syndrome
|
98
|
19
|
0.010 |
None |
1.000 |
1 |
2
|
2017 |
2017 |
Progressive Neoplastic Disease
|
phenotype |
|
Neoplastic Process
|
384
|
40
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Severe malnutrition
|
disease |
|
Disease or Syndrome
|
13
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Aplasia Cutis Congenita
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases
|
Congenital Abnormality
|
393
|
14
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Agenesis of corpus callosum
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Congenital Abnormality
|
615
|
45
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Cholangiocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
877
|
43
|
0.010 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Mastocytosis, Systemic
|
disease |
Neoplasms; Immune System Diseases
|
Neoplastic Process
|
94
|
11
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Anemia, severe
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
65
|
6
|
0.010 |
None |
< 0.001 |
1 |
1
|
2015 |
2015 |
Primary amyloidosis
|
disease |
Neoplasms; Nutritional and Metabolic Diseases; Immune System Diseases
|
Disease or Syndrome
|
59
|
11
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Xerocytosis
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
20
|
3
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Carcinoma breast stage IV
|
disease |
|
Neoplastic Process
|
573
|
14
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Secondary malignant neoplasm of lymph node
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2825
|
188
|
0.010 |
None |
< 0.001 |
1 |
|
2017 |
2017 |
Biliary Tract Cancer
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
167
|
11
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Infection caused by Helicobacter pylori
|
disease |
Infections
|
Disease or Syndrome
|
337
|
56
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Transfusion dependent anaemia
|
disease |
|
Disease or Syndrome
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Progressive cGVHD
|
disease |
|
Disease or Syndrome
|
384
|
40
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |